Menu Search
Equities

Alzchem Group AG

ACT:BRN

Alzchem Group AG

Actions
  • Price (CHF)49.61
  • Today's Change-1.83 / -3.56%
  • Shares traded120.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 11 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Alzchem Group AG, fka AlzChem Group AG, is a Germany-based group parent company for a vertically integrated producer of chemical products based on the calcium carbide/calcium cyanamide chain. The Group's operating business is divided into three segments: Specialty Chemicals, Basics & Intermediates and Other & Holding. Its products can be applied in areas, such as nutrition, renewable energy, fine chemicals, agriculture and metallurgy. The Company produces dietary supplements; epoxy resin hardeners for use in adhesives, powder coatings, printed circuit boards and composites; silicon nitride for advanced ceramics and solar wafers; technical gases; specialty fertilizer, germicide for use in pig pens, plant growth regulators and plant protection additives, among others. It also provides related services. The Company operates production sites in Germany and Sweden, a sales subsidiary in the United States and a Chinese subsidiary for the purchase of raw materials and distribution in Asia.

  • Revenue in EUR (TTM)557.99m
  • Net income in EUR50.10m
  • Incorporated2017
  • Employees1.69k
  • Location
    Alzchem Group AGChemiepark TrostbergDr. Albert-Frank-Str. 32TROSTBERG 83308GermanyDEU
  • Phone+49 8621860
  • Fax+49 8 621862911
  • Websitehttps://www.alzchem.com/de
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.